13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The Korean Version of the University of California San Diego Performance-based Skills Assessment: Reliability and Validity

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective

          The study’s aim was to develop and standardize a Korean version of the University of California San Diego Performance-based Skills Assessment (K-UPSA), which is used to evaluate the daily living function of patients with schizophrenia.

          Methods

          Study participants were 78 patients with schizophrenia and 27 demographically matched healthy controls. We evaluated the clinical states and cognitive functions to verify K-UPSA’s reliability and validity. For clinical states, the Positive and Negative Syndrome Scale, Clinical Global Impression-Schizophrenia scale, and Social and Occupational Functioning Assessment Scale and Schizophrenia Quality of Life Scale-fourth revision were used. The Schizophrenia Cognition Rating Scale, Short-form of Korean-Wechsler Adult Intelligence Scale, and Wisconsin Card Sorting Test were used to assess cognitive function.

          Results

          The K-UPSA had statistically significant reliability and validity. The K-UPSA has high internal consistency (Cronbach’s alpha, 0.837) and test-retest reliability (intra-class correlation coefficient, 0.381–0.792; p<0.001). The K-UPSA had significant discriminant validity ( p<0.001). Significant correlations between the K-UPSA’s scores and most of the scales and tests listed above demonstrated K-UPSA’s concurrent validity ( p<0.001).

          Conclusion

          The K-UPSA is useful to evaluate the daily living function in Korean patients with schizophrenia.

          Related collections

          Most cited references32

          • Record: found
          • Abstract: found
          • Article: not found

          The positive and negative syndrome scale (PANSS) for schizophrenia.

          The variable results of positive-negative research with schizophrenics underscore the importance of well-characterized, standardized measurement techniques. We report on the development and initial standardization of the Positive and Negative Syndrome Scale (PANSS) for typological and dimensional assessment. Based on two established psychiatric rating systems, the 30-item PANSS was conceived as an operationalized, drug-sensitive instrument that provides balanced representation of positive and negative symptoms and gauges their relationship to one another and to global psychopathology. It thus constitutes four scales measuring positive and negative syndromes, their differential, and general severity of illness. Study of 101 schizophrenics found the four scales to be normally distributed and supported their reliability and stability. Positive and negative scores were inversely correlated once their common association with general psychopathology was extracted, suggesting that they represent mutually exclusive constructs. Review of five studies involving the PANSS provided evidence of its criterion-related validity with antecedent, genealogical, and concurrent measures, its predictive validity, its drug sensitivity, and its utility for both typological and dimensional assessment.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS.

            It is generally accepted that cognitive deficits in schizophrenia are related to functional outcome. However, support for longitudinal relationships between cognition and functional outcome has not been as well documented. The current paper presents a review of 18 recently published longitudinal studies (minimum 6-month follow up) of the relationships between cognition and community outcome in schizophrenia. Results from these studies reveal considerable support for longitudinal associations between cognition and community outcome in schizophrenia. These studies demonstrate that cognitive assessment predict later functional outcome and provide a rationale for psychopharmacological interventions for cognitive deficits in schizophrenia. Although the relationships between cognition and community outcome are well-supported, it is clear that community functioning is also affected by a host of factors apart from cognition that are usually not considered in clinical trial studies (e.g., psychosocial rehabilitation and educational/vocational opportunities). In the second part of the paper, we consider intervening steps between cognitive performance measures and community outcome. These steps are apt to have important implications for clinical trials of cognition-enhancing agents in schizophrenia.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Sample size requirements for estimating pearson, kendall and spearman correlations

                Bookmark

                Author and article information

                Journal
                Clin Psychopharmacol Neurosci
                Clin Psychopharmacol Neurosci
                Clinical Psychopharmacology and Neuroscience
                Korean College of Neuropsychopharmacology
                1738-1088
                2093-4327
                August 2017
                31 August 2017
                : 15
                : 3
                : 261-268
                Affiliations
                [1 ]Department of Psychiatry, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
                [2 ]Shim Joo Cheol Psychiatry Clinic, Busan, Korea
                [3 ]Department of Psychiatry, Busan Metropolitan Mental Hospital, Busan, Korea
                [4 ]Department of Psychiatry, Sharing and Happiness Hospital, Busan, Korea
                [5 ]Department of Psychiatry, Samsung Changwon Hospital, Sungkyunkwan University College of Medicine, Changwon, Korea
                Author notes
                Address for correspondence: Do-Un Jung, MD, PhD, Department of Psychiatry, Busan Paik Hospital, Inje University College of Medicine, 75 Bokji-ro, Busanjin-gu, Busan 47392, Korea, Tel: +82-51-890-6189, Fax: +82-51-894-2532, E-mail: gabriel.jdu@ 123456gmail.com
                Article
                cpn-15-261
                10.9758/cpn.2017.15.3.261
                5565087
                28783936
                9ef7d1da-3095-4748-8f0a-9602c1267063
                Copyright © 2017, Korean College of Neuropsychopharmacology

                This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 25 October 2016
                : 15 December 2016
                : 16 December 2016
                Categories
                Original Article

                cognitive function,reliability,schizophrenia,validity
                cognitive function, reliability, schizophrenia, validity

                Comments

                Comment on this article